David A Horne

USPTO Granted Patents = 60 (Patent Applications = 21)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 166(Granted Patents)

Forward Citations (Not Self Cited) = 115(Dec 10, 2025)

Inventors with similar research interests:

Location History:

New York, NY (US) (1998 - 2003)
Los Angeles, CA (US) (2019)
Duarte, CA (US) (2014 - 2023)
Altadena, CA (US) (2009 - 2024)

Company Filing History:

University of California

California Institute of Technology

patents

5. 3 out of 7

National and Kapodistrian University of Athens

patents

6. 1 out of 1,630

University of Southern California

patents

7. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Wnt Signaling Pathway

PCNA Inhibitors

Berbamine Derivatives

DNA2 Inhibitors

Ribonucleotide Reductase Inhibitors

T-cell Lymphoma Treatments

Thioindirubins

Adipocyte Modulators

Meditopes

Cancer Treatment

Prostate Cancer

Photocleavable Linkers

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486275 - Substituted pyrazino[2,1-c][1,2,4]triazines as Wnt/CBP/catenin signaling pathway inhibitors (2025-12-02),

2. 12435030 - PCNA inhibitors (2025-10-07),

3. 12173000 - Berbamine derivatives and methods of use thereof (2024-12-24),

4. 12054447 - PCNA inhibitors (2024-08-06),

5. 11974993 - Solution formulations of CX-011 (2024-05-07),

6. 11964941 - 5-Bromo-indirubins (2024-04-23),

7. 11897952 - Mechanically interlocking complexes (2024-02-13),

8. 11858879 - PARG inhibitors and method of use thereof (2024-01-02),

9. 11780815 - DNA2 inhibitors for cancer treatment (2023-10-10),

10. 11766442 - T-cell lymphoma treatments (2023-09-26),

11. 11759530 - TKI permeability enhancers (2023-09-19),

12. 11584760 - Dithio ETP derivatives (2023-02-21),

13. 11583509 - Compound for treating cancer and diabetes (2023-02-21),

14. 11541062 - Methods of treating advanced prostate cancer (2023-01-03),

15. 11345656 - PCNA inhibitors (2022-05-31),

Title: The Innovative Mind of David A. Horne

Introduction: David A. Horne is a distinguished inventor based in Duarte, California. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology through his inventive spirit and dedication.

Latest Patents: David A. Horne holds several patents in various technological domains, showcasing his versatility and ingenuity in developing novel ideas that push the boundaries of innovation.

Career Highlights: Throughout his illustrious career, David A. Horne has been recognized for his pioneering work in the tech industry. His innovative approach to problem-solving has led to the development of cutting-edge solutions that have had a lasting impact on the field.

Collaborations: David A. Horne has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: David A. Horne's relentless pursuit of innovation and his commitment to pushing the limits of what is possible make him a true visionary in the world of technology. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.

This text is generated by artificial intelligence and may not be accurate.